Patenting and strategies of major pharmaceutical companies in Brazil

Detalhes bibliográficos
Autor(a) principal: Acioli, Gláucia Rocha
Data de Publicação: 2020
Outros Autores: Abud, Ana Karla de Souza, Oliveira Júnior, Antonio Martins de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/6896
Resumo: Facing the contemporaneous changes which have intensified the market competition, survival strategies are essential for the company sustainability, such as the protection of intangible assets through the patents, which confer several advantages. In the pharmaceutical industry, where the products are result from expensive processes, the patents have become an important incentive. This article has undertaken a systematic analysis of patenting in the Brazilian pharmaceutical industry, evaluating the patents indicators of the major pharmaceutical companies in Brazil in order to categorize their strategies. The results indicated the leadership of Aché in patent applications, an extremely small number of concessions, characterizing the majority of the deposits as Invention Patents, and the lack of partnerships with universities and /or foundations for research support. The EMS and Eurofarma companies have presented analytical strategic performance, the União Química, defender, and Aché and Hypermarcas, prospector performance.
id UNIFEI_46150eef2a55a78f7943b41053977e7a
oai_identifier_str oai:ojs.pkp.sfu.ca:article/6896
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Patenting and strategies of major pharmaceutical companies in BrazilPatentes y estrategias de las principales compañías farmacéuticas en BrasilPatentes e estratégias das principais empresas farmacêuticas do Brasil EstratégiasIndicadoresIndústria farmacêuticaPatentes.EstrategiasIndicadoresIndustria farmacéuticaPatentes.StrategiesIndicatorsPharmaceutical industryPatents.Facing the contemporaneous changes which have intensified the market competition, survival strategies are essential for the company sustainability, such as the protection of intangible assets through the patents, which confer several advantages. In the pharmaceutical industry, where the products are result from expensive processes, the patents have become an important incentive. This article has undertaken a systematic analysis of patenting in the Brazilian pharmaceutical industry, evaluating the patents indicators of the major pharmaceutical companies in Brazil in order to categorize their strategies. The results indicated the leadership of Aché in patent applications, an extremely small number of concessions, characterizing the majority of the deposits as Invention Patents, and the lack of partnerships with universities and /or foundations for research support. The EMS and Eurofarma companies have presented analytical strategic performance, the União Química, defender, and Aché and Hypermarcas, prospector performance.Frente a los cambios contemporáneos que han intensificado la competencia en el mercado, las estrategias de supervivencia son esenciales para la sostenibilidad de la empresa, como la protección de activos intangibles a través de las patentes, que confieren varias ventajas. En la industria farmacéutica, donde los productos son el resultado de procesos costosos, las patentes se han convertido en un incentivo importante. Este artículo ha llevado a cabo un análisis sistemático de patentes en la industria farmacéutica brasileña, evaluando los indicadores de patentes de las principales compañías farmacéuticas en Brasil para clasificar sus estrategias. Los resultados indicaron el liderazgo de Aché en las solicitudes de patentes, un número extremadamente pequeño de concesiones, caracterizando a la mayoría de los depósitos como Patentes de Invención, y la falta de asociaciones con universidades y / o fundaciones para el apoyo a la investigación. Las empresas EMS y Eurofarma han presentado el desempeño analítico estratégico, el União Química, defensor, y Aché e Hypermarcas, el desempeño prospectivo.Diante das mudanças contemporâneas que intensificaram a concorrência no mercado, estratégias de sobrevivência são essenciais para a sustentabilidade de uma empresa, como a proteção de ativos intangíveis por meio das patentes, que conferem diversas vantagens. Na indústria farmacêutica, onde os produtos são resultado de processos caros, as patentes se tornaram um incentivo importante. Este artigo realizou uma análise sistemática de patentes na indústria farmacêutica brasileira, avaliando os indicadores de patentes das principais empresas farmacêuticas no Brasil, a fim de categorizar suas estratégias. Os resultados indicaram a liderança da Aché em pedidos de patentes, um número extremamente pequeno de concessões, caracterizando a maioria dos depósitos como Patentes de Invenção, e a falta de parcerias com universidades e/ou fundações para apoio à pesquisa. As empresas EMS e Eurofarma apresentaram desempenho estratégico analítico, a União Química, defensor, e Aché e Hypermarcas, desempenho prospectivo.Research, Society and Development2020-08-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/689610.33448/rsd-v9i9.6896Research, Society and Development; Vol. 9 No. 9; e264996896Research, Society and Development; Vol. 9 Núm. 9; e264996896Research, Society and Development; v. 9 n. 9; e2649968962525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/6896/6409Copyright (c) 2020 Ana Karla Abud, Gláucia Rocha Acioli, Antonio Martins Oliveira Júniorhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAcioli, Gláucia RochaAbud, Ana Karla de SouzaOliveira Júnior, Antonio Martins de2020-09-18T01:42:11Zoai:ojs.pkp.sfu.ca:article/6896Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:29:50.816032Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Patenting and strategies of major pharmaceutical companies in Brazil
Patentes y estrategias de las principales compañías farmacéuticas en Brasil
Patentes e estratégias das principais empresas farmacêuticas do Brasil
title Patenting and strategies of major pharmaceutical companies in Brazil
spellingShingle Patenting and strategies of major pharmaceutical companies in Brazil
Acioli, Gláucia Rocha
Estratégias
Indicadores
Indústria farmacêutica
Patentes.
Estrategias
Indicadores
Industria farmacéutica
Patentes.
Strategies
Indicators
Pharmaceutical industry
Patents.
title_short Patenting and strategies of major pharmaceutical companies in Brazil
title_full Patenting and strategies of major pharmaceutical companies in Brazil
title_fullStr Patenting and strategies of major pharmaceutical companies in Brazil
title_full_unstemmed Patenting and strategies of major pharmaceutical companies in Brazil
title_sort Patenting and strategies of major pharmaceutical companies in Brazil
author Acioli, Gláucia Rocha
author_facet Acioli, Gláucia Rocha
Abud, Ana Karla de Souza
Oliveira Júnior, Antonio Martins de
author_role author
author2 Abud, Ana Karla de Souza
Oliveira Júnior, Antonio Martins de
author2_role author
author
dc.contributor.author.fl_str_mv Acioli, Gláucia Rocha
Abud, Ana Karla de Souza
Oliveira Júnior, Antonio Martins de
dc.subject.por.fl_str_mv Estratégias
Indicadores
Indústria farmacêutica
Patentes.
Estrategias
Indicadores
Industria farmacéutica
Patentes.
Strategies
Indicators
Pharmaceutical industry
Patents.
topic Estratégias
Indicadores
Indústria farmacêutica
Patentes.
Estrategias
Indicadores
Industria farmacéutica
Patentes.
Strategies
Indicators
Pharmaceutical industry
Patents.
description Facing the contemporaneous changes which have intensified the market competition, survival strategies are essential for the company sustainability, such as the protection of intangible assets through the patents, which confer several advantages. In the pharmaceutical industry, where the products are result from expensive processes, the patents have become an important incentive. This article has undertaken a systematic analysis of patenting in the Brazilian pharmaceutical industry, evaluating the patents indicators of the major pharmaceutical companies in Brazil in order to categorize their strategies. The results indicated the leadership of Aché in patent applications, an extremely small number of concessions, characterizing the majority of the deposits as Invention Patents, and the lack of partnerships with universities and /or foundations for research support. The EMS and Eurofarma companies have presented analytical strategic performance, the União Química, defender, and Aché and Hypermarcas, prospector performance.
publishDate 2020
dc.date.none.fl_str_mv 2020-08-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/6896
10.33448/rsd-v9i9.6896
url https://rsdjournal.org/index.php/rsd/article/view/6896
identifier_str_mv 10.33448/rsd-v9i9.6896
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/6896/6409
dc.rights.driver.fl_str_mv Copyright (c) 2020 Ana Karla Abud, Gláucia Rocha Acioli, Antonio Martins Oliveira Júnior
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Ana Karla Abud, Gláucia Rocha Acioli, Antonio Martins Oliveira Júnior
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 9; e264996896
Research, Society and Development; Vol. 9 Núm. 9; e264996896
Research, Society and Development; v. 9 n. 9; e264996896
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052803224436736

Registros relacionados